Effects of Tanshinone II_A on SDF-1/CXCR4 from peripheral blood in patients with type 2 diabetes mellitus
QI Chuan-ping
Abstract
QI Chuan-ping
Abstract
AIM To study effect of TanshinoneⅡA(TanⅡA) on stromal cell-derived factor-1(SDF-1) and it's receptors CXCR4 in patients with type 2 diabetes mellitus(T2DM).METHODS Sixty-two patients with T2DM were randomly divided into treatment and control groups.TanⅡA 40 mg·d-1 was given to patients in treatment group for 2 weeks.The level of plasma SDF-1,the positive rate of CXCR4 on endothelial progenitor cells(EPCs)and the number of EPCs were determined pre-and post-treatment.RESULTS All parameters had no significant differences between 2 groups before observation(P0.05).Increasing SDF-1,EPCs and CXCR4 had significant difference in the treatment group pre-and post-treatment(P0.05 or P0.01).The parameters had no significant differences between before and after observation in the control group(P0.05).There was a significant positive correlation between EPCs and SDF-1(r=0.223,P0.05).CONCLUSION TanⅡA can improve vascular endothelial function in T2DM,which may be due to elevating the level of plasma SDF-1 and increasing the expression of CXCR4 on EPCs,and inducing EPCs mobilization from bone marrow to peripheral blood.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM To study effect of TanshinoneⅡA(TanⅡA) on stromal cell-derived factor-1(SDF-1) and it's receptors CXCR4 in patients with type 2 diabetes mellitus(T2DM).METHODS Sixty-two patients with T2DM were randomly divided into treatment and control groups.TanⅡA 40 mg·d-1 was given to patients in treatment group for 2 weeks.The level of plasma SDF-1,the positive rate of CXCR4 on endothelial progenitor cells(EPCs)and the number of EPCs were determined pre-and post-treatment.RESULTS All parameters had no significant differences between 2 groups before observation(P0.05).Increasing SDF-1,EPCs and CXCR4 had significant difference in the treatment group pre-and post-treatment(P0.05 or P0.01).The parameters had no significant differences between before and after observation in the control group(P0.05).There was a significant positive correlation between EPCs and SDF-1(r=0.223,P0.05).CONCLUSION TanⅡA can improve vascular endothelial function in T2DM,which may be due to elevating the level of plasma SDF-1 and increasing the expression of CXCR4 on EPCs,and inducing EPCs mobilization from bone marrow to peripheral blood.
Key concepts: Stromal cell-derived factor 1, CXCR4, Progenitor cell, Stromal cell, Endothelial progenitor cell, Medicine, Type 2 Diabetes Mellitus, Internal medicine